Newborn Hearing Loss
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Ankara City Hospital Bilkent
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Hearing Loss
Study Overview
Brief Summary
This study aims to investigate the presence and characteristics of maternal diabetes as a risk factor in newborns with hearing loss.
Hearing loss is one of the most common congenital anomalies among newborns. The newborn hearing screening program is important for early diagnosis in newborns with hearing loss.Gestational diabetes, on the other hand, is a metabolic disease that occurs during pregnancy and can cause complications as in other diabetes mellitus patients.
Despite our knowledge of major complications, the effect of the hyperglycemic intrauterine environment on hearing outcomes has not been adequately studied. The inner ear does not store energy, so it has a particularly high sensitivity to altered blood sugar and insulin. Altered inner ear metabolism leads to auditory and balance disorders.
There is no study in the literature comparing uncomplicated gestational diabetes and pregestational diabetes as a prenatal complication that poses a risk of hearing loss.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 1 Day to 28 Days (Child)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •POSTNATAL AGE BETWEEN 0-28 DAYS
- •BIRTH WEIGHT ≥2000GR
- •TO HAVE TESTED ON THE NEWBORN HEARING SCREENING UNIT AT ANKARA CITY HOSPITAL
Exclusion Criteria
- •CRANIOFACIAL ANOMALIES
- •INTRAUTERINE INFECTIONS
- •BIRTH WEIGHT <2000 GR
Outcomes
Primary Outcomes
Hearing Loss
Time Frame: 6 months
Hearing test results in babies with no diabetes, pregestational diabetes, and gestational diabetes
Secondary Outcomes
- diabetic mother(6 months)